New Marchand Institute Study Shows effect of a 20% intravenous fat emulsion therapy on IVF and ICSI
Just published in the Journal of Clinical and Translational Research, The Marchand Institute’s new study on 20% intravenous fat emulsion therapy (also known as IntralipidTM), shows the effect of this medication on patients who suffer from recurrent pregnancy loss (RPL) and recurrent implantation failure (RIF) who are seeking to conceive via invitro fertilization (IVF) or…
